Try not to perspire it: Chilean canines track down coronavirus in beginning phases Kumar Jeetendra | August 1, 2020 Chilean police are training sniffer dogs to discover the coronavirus in people’s sweat for an early period, after a similar trial in the UK showed encouraging results. Four dogs are chosen for the initial training, a mixture of labradors and golden retrievers who game green”biodetector” jackets for their task. They are being trained at the …
Sterile 96-Well Plate Seal for Cell Culturing by BioChromato Kumar Jeetendra | August 2, 2020 BioChromato, Fujisawa, Japan, has introduced a gamma sterilized version of its Rapid Slit Seal for scientists seeking to eliminate solvent evaporation from samples when culturing cells from 96-well microplates. Rapid Slit Seal is a proprietary self-closing microplate seal which returns to its initial state even when punched having an HPLC or even LC/MS autosampler. This …
Cipla scales up assembling of remdesivir to fulfill high need Kumar Jeetendra | August 11, 2020 Medicine manufacturer Cipla said on Tuesday it is rising up the production of antiviral drug remdesivir, used in COVID-19 treatment, by manufacturing the drug at its Goa plant. “Presently the requirement is enormous for remdesivir, also we’re scaling up our internal production of Remdesivir,” Kedar Upadhye, global chief financial officer of Cipla, told Moneycontrol. Upadhye …
Gargled water tests might be feasible option in contrast to swabs for identification of COVID-19: Study Kumar Jeetendra | August 21, 2020 Gargled water samples might be a feasible alternative to swabs for detection of COVID-19, enabling easy self-collection and taking away the need for trained health care workers for sample collection, according to a study published at the ICMR’s Indian Journal of Medical Research. Adoption of gargle lavage for sample group will have a significant effect …
Kids are quiet spreaders of COVID-19: Study Kumar Jeetendra | August 21, 2020 Kids play a larger part in the community spread of COVID-19 than previously thought, according to a study which found that the younger individuals might not be as inclined to become seriously sick as adults, but they can spread infection and bring the virus into their houses. The study, published in the Journal of Pediatrics, …
FDC dispatches 2 variations of Favipiravir in India at Rs 55 for each tablet Kumar Jeetendra | August 25, 2020 Drug firm FDC Ltd on Tuesday said it has established two variants of this COVID-19 drug Favipiravir under the brand names PiFLU and Favenza. The Drug Controller General of India (DCGI) had previously approved the use of Favipiravir, an off patent, oral antiviral drug that’s been demonstrated to quicken clinical healing from COVID-19 patients with …
Oxford covid antibody: No reactions seen as more volunteers get Covishield in India Kumar Jeetendra | August 28, 2020 Five volunteers were given Oxford covid-19 vaccine at Pune district Thursday as part of this phase II clinical trial. Three of these volunteers have been administered the Oxford COVID-19 vaccine candidate in Bharti Vidyapeeth’s Medical College and Hospital at Pune town while two more volunteers were inoculated with the Oxford COVID-19 vaccine candidate at the …
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2 Kumar Jeetendra | September 8, 2020 TEL AVIV, Israel and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that opaganib1 demonstrated potent inhibition of SARS-CoV-2, the virus that causes COVID-19, achieving complete blockage of viral replication in an in vitro model of human lung bronchial tissue. …
Why the Covid death rate actually escapes researchers Kumar Jeetendra | September 29, 2020 Global deaths from COVID-19 have reached 1 million, but experts are still struggling to figure out a key metric in the pandemic: the fatality rate – the percentage of people infected with the pathogen who die. A true mortality rate could compare deaths against the entire number of ailments, a denominator that remains unknown because …
Russia finishes clinical preliminaries of second potential COVID-19 immunization Kumar Jeetendra | September 30, 2020 Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency mentioned Russian customer safety watchdog Rospotrebnadzor as saying on Wednesday The institute completed early-stage human trials, known as Phase II, earlier this month.
GlaxoSmithKline CEO hopeful COVID-19 immunization generally accessible in 2021 Kumar Jeetendra | September 30, 2020 The chief executive of GlaxoSmithKline, the world’s largest maker of vaccines, said she was convinced that the industry will have the ability to make an immunisation against COVID-19 widely available next year. “I share the optimism that we’ll have solutions next year. The challenge here is getting into the scale that’s required,” GSK CEO Emma …
Covid immunization: Bharat Biotech to utilize ViroVax’s adjuvant for Covaxin Kumar Jeetendra | October 5, 2020 Trials, will use adjuvant Alhydroxiquim-II to boost immune response and longer lasting immunity. The technology has been used under this licensing arrangement with US-based ViroVax. Adjuvant is used to boost the vaccine efficacy. Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2 virus, isolated in the National Institute of Virology (NIV), Pune under …
